세계 인공혈관 시장 규모는 2023년 21억 9,000만 달러로 평가되었고, 2030년까지 30억 7,000만 달러에 달할 것으로 예상되며, 2024-2030년의 예측 기간 동안 연평균 5.02% 성장할 것으로 예상됩니다. 인공 혈관에 대한 수요는 주로 노인 인구의 급속한 증가와 다양한 심혈관 질환의 유병률 증가에 의해 주도되고 있습니다. 또한, 기술 발전, 이 분야에서 진행 중인 수많은 연구 활동, 의료 서비스 제공업체, 연구자 및 업계 기업간의 제휴, 전략적 파트너십 등의 이유로 시장이 성장할 것으로 예상되며, 이는 2024-2030년의 예측 기간 동안 시장의 전반적인 성장에 기여할 것으로 예상됩니다.
인공혈관 시장 역학
심혈관 질환은 전 세계적으로 매우 흔한 질병이며, 그 중에서도 관상동맥 질환과 말초혈관 질환이 가장 큰 비중을 차지합니다. 예를 들어, 미국심장협회(American Heart Association)(2022)에 따르면 2020년 전 세계적으로 약 2억 4,410만 명이 관상동맥(허혈성) 심장질환을 앓고 있다고 합니다. 이 자료에 따르면 북아프리카, 중동, 중앙아시아, 남아시아, 동유럽은 2020년 관상동맥성(허혈성) 심장병 유병률이 세계에서 가장 높은 지역입니다.
영국 심장재단(British Heart Foundation)의 2022년 자료에 따르면, 2019년 전 세계적으로 약 5억 5,000만 명(14명 중 1명)이 심장 및 순환기 질환을 앓고 있으며, 이 중 약 2억 9,000만 명의 여성과 약 2억 6,000만 명의 남성을 포함한 포함됩니다. 같은 자료에 따르면 2019년 북미에서는 410만 3,135명이 심혈관 질환을 앓고 있으며, 108만 9,947명이 관상동맥질환, 49만 8,551명이 뇌졸중을 앓고 있고, 아시아에서는 3,237만 6,834명이 심혈관 질환을 앓고 있으며, 이 중 1,254만 3,833명이 관상동맥질환을 앓고 있다고 합니다. 관상동맥질환을 앓고 있으며, 811만 1,044명이 뇌졸중을 앓고 있습니다.
상기 자료는 관상동맥(허혈성) 심장질환, 말초동맥(혈관) 질환, 뇌졸중, 심방세동이 2019년에도 세계에서 가장 흔하고 유병률이 높은 심혈관 질환으로 나타났다고 밝혔습니다.
혈관의 협착, 막힘 또는 심각한 기능 장애는 심혈관 질환의 다양한 병태 생리적 메커니즘 중 하나입니다. 대동맥은 특히 복부 대동맥류, 대동맥 경색, 만성 혈액 투석 접근과 같은 다양한 병적 상태에 의해 영향을 받는 경향이 있습니다.
폐색된 혈관 구조를 치료하기 위해 인공혈관을 사용하는 인공혈관 치환술이 선호되는 수술 옵션입니다. 인공혈관에 대한 수요는 수술 후 합병증 발생률뿐만 아니라 건강한 자가 혈관의 가용성이 제한적이기 때문에 증가하고 있는 추세입니다.
또한, 새로운 인공혈관 개발에 대한 지속적인 연구 활동은 당분간 시장 성장을 가속화할 것으로 예상됩니다. 예를 들어, 2022년 9월, 덴마크 남부대학교(SDU)와 오덴세대학병원(OUH)의 연구진은 막힘과 감염을 방지하는 획기적인 인공혈관 개발에 착수했습니다.
그러나 인공혈관 제조 및 개발 과정에서 직면하는 어려움과 인공혈관 관련 규제 준수 및 기타 안전에 대한 우려는 전체 인공혈관 시장의 성장을 저해할 수 있습니다.
인공혈관 시장 부문별 분석
인공혈관 시장의 응용 분야 중 말초동맥질환 부문은 2023년 큰 매출 점유율을 차지할 것으로 예상됩니다. 이는 말초동맥질환의 유병률 증가에 기인하는 것으로 보입니다.
예를 들어, 캐나다 통계청의 최신 조사에 따르면 PAD는 국내에서 널리 퍼져 있으며, 매년 약 80만 명의 캐나다인이 발병하고 있습니다.
또한, 고령, 흡연, 고혈압 등 말초동맥질환과 관련된 위험요인 증가는 인공혈관 시장의 성장을 더욱 부추기고 있습니다.
Canadian Census 2021에 따르면 2021년 85세 이상 인구가 86만 1,000명을 넘어섰다고 합니다. 앞서 언급한 자료에 따르면 2016년부터 2021년까지 85세 이상 인구는 12% 증가했으며, 이는 캐나다 전체 인구 증가율의 두 배 이상이라고 합니다.
이 보고서는 세계 인공혈관 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등을 조사 분석하여 전해드립니다.
Artificial Blood Vessels Market By Polymer Type (Polydioxanone, Elastomer, Polyethylene Terephthalate, And Others), Application (Aortic Disease, Peripheral Artery Disease, And Hemodialysis), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the prevalence of cardiovascular diseases (CVDS) and increasing research and development activities
The global artificial blood vessels market was valued at USD 2.19 billion in 2023, growing at a CAGR of 5.02% during the forecast period from 2024 to 2030 to reach USD 3.07 billion by 2030. The demand for artificial blood vessels is primarily being boosted by the rising prevalence of various cardiovascular diseases coupled with a rapidly growing geriatric population. Furthermore, the artificial blood vessels market is anticipated to grow on account of the growing technological advancement, a large number of ongoing research activities in this field, collaborations between healthcare providers, researchers, and industry players, and strategic partnerships among others are going to contribute in the overall growth of the artificial blood vessels market during the forecast period from 2024-2030.
Artificial Blood Vessels Market Dynamics:
Cardiovascular diseases are highly prevalent across the globe, of which the largest proportion is taken by coronary and peripheral vascular diseases. For instance, according to the American Heart Association 2022, globally, about 244.1 million people were living with coronary (ischemic) heart disease in 2020. As per the same source, North Africa, the Middle East, Central and South Asia, and Eastern Europe had the highest prevalence rates of coronary (ischemic) heart disease in the world in 2020.
As per the data provided by British Heart Foundation 2022, worldwide around 550 million which stands for 1 in 14 people were living with heart and circulatory diseases in 2019 and this includes about 290 million women and around 260 million men. As per the same source, in 2019, in North America, cardiovascular diseases affected 4,103,135 people, 1,089,947 people were diagnosed with coronary artery disease, and 498,551 suffered from stroke; In Asia, there were 32,376,834 people diagnosed with cardiovascular diseases, from which 12,543,833 individuals were affected by coronary artery disease, and 8,111,044 population was suffered from a stroke.
The source mentioned above further stated that coronary (ischemic) heart disease (200 million cases), peripheral arterial (vascular) disease (110 million cases), stroke (100 million cases), and atrial fibrillation (60 million cases) remained the commonest and prevalent cardiovascular conditions worldwide in 2019.
Stenosis, occlusion, or severe dysfunction of blood vessels are among various pathophysiological mechanisms of cardiovascular diseases. The aorta tends to be affected by a range of disease conditions including abdominal aortic aneurysm, coarctation of the aorta, and chronic hemodialysis access among others.
For the treatment of obstructed vascular structures, vascular replacement involving the usage of artificial blood vessels is the preferred surgical option. The demand for artificial blood vessels is also on the rise due to the limited availability of healthy autologous vessels as well as the incidence of postoperative complications.
Similarly, ongoing research activities about the development of novel artificial blood vessels will accelerate market growth in the foreseeable future. For example, in September 2022, University of Southern Denmark (SDU) and Odense University Hospital (OUH) researchers are working on the development of a revolutionary artificial blood vessel that is prevented from closing or becoming infected.
However, regulatory compliance and other safety concerns associated with artificial blood vessels along with challenges encountered during manufacturing and development of artificial blood vessels may restrict the growth of the overall artificial blood vessels market.
Artificial Blood Vessels Market Segment Analysis:
Artificial Blood Vessels Market by Polymer Type (Polydioxanone, Elastomer, Polyethylene Terephthalate, and Others), Application (Aortic Disease, Peripheral Artery Disease, and Hemodialysis), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the application segment of the artificial blood vessels market, the peripheral artery disease category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the rising prevalence of peripheral artery disease.
For instance, as per the latest study provided by Statistic Canada, PAD is widely prevalent in the country, affecting approximately 800,000 Canadians, every year.
Also, the rise in the number of risk factors such as old age, smoking, hypertension, and others associated with peripheral artery disease is further boosting the market growth for artificial blood vessels.
As per the Canadian Census 2021, over 861,000 people aged 85 and older were counted in 2021. The aforesaid source also stated that, between 2016 and 2021, the number of people aged 85 and older grew by 12%, which is more than twice as high as the growth seen for the overall Canadian population.
According to the facts and figures provided by WHO in 2022, it was estimated that in Spain, almost every fifth of adults and adolescents smoke.
The same source stated that almost 18% of adults smoked tobacco in the year 2020 and 21% of adolescents aged 15-16 smoked cigarettes in 2019. The increasing consumption of tobacco and smoking among adults and youngsters will make them more prone to cardiovascular disorders such as PAD, and others.
By replacing the damaged native blood vessels, artificial blood vessels help to treat severe cases of peripheral artery disease.
Therefore, owing to the above-mentioned factors, the peripheral artery disease category is expected to register significant growth, thereby driving the growth of the overall artificial blood vessels market during the forecast period.
North America Is Expected To Dominate The Overall Artificial Blood Vessels Market:
Among all the regions, North America is estimated to account for the largest share of the Artificial Blood Vessels market in the year 2023. Owing to the significance of key growth factors such as the increased mortality rate due to aortic aneurysm, rise in cases of peripheral artery disease and coronary artery diseases among other cardiovascular disease conditions, growing awareness programs and initiatives related to heart health, high disposable income, sophisticated healthcare infrastructure, presence of key players, increasing product development activities, and others, the market for artificial blood vessels is expected to witness prosperity in the region during the forecast period 2024-2030.
The Centers for Disease Control and Prevention (CDC) 2021 highlighted that aortic aneurysms or aortic dissections were responsible for causing about 9,904 deaths in 2019 in the United States. As per the same source, 59% of those deaths occurred among men. The number of deaths due to aortic aneurysms could have been avoided with proper surgical treatment via the utilization of artificial blood vessels.
As per the Centers for Disease Control and Prevention 2022, approximately 6.5 million people aged 40 and older were there with peripheral artery disease (PAD) condition in 2021 in the United States.
Another factor contributing to the growth of the artificial blood vessels market is the continued rise in the number of individuals involved in smoking. For instance, as per the Centers for Disease Control and Prevention 2022, approximately 40 million people smoke cigarettes in the US. As per the same source, every day nearly 1,600 US youth aged 18 years or younger smoke their first cigarette. Smoking increases the risk for a range of cardiovascular disease conditions.
Thus, the above-mentioned factors are likely to propel the growth of the artificial blood vessels market in the region during the forecast period from 2024-2030.
Artificial Blood Vessels Market Key Players:
Some of the key market players operating in the Artificial Blood Vessels market include LeMaitre Vascular Inc., Terumo Medical Corporation, W. L. Gore and Associates, B. Braun SE, Roumai Med, Jiangsu Bioda Life Science Co. Ltd., Artivion, Inc., Getinge, Vygon, and others.
Recent Developmental Activities In The Artificial Blood Vessels Market:
Key Takeaways From The Artificial Blood Vessels Market Report Study
Target Audience Who Can Be Benefited From This Artificial Blood Vessels Market Report Study
Frequently Asked Questions For The Artificial Blood Vessels Market:
Artificial blood vessels are represented as ideal vascular grafts that are composed of viable tissues. They offer advantages including compliance, lack of thrombogenicity, and resistance to infections among others.
The artificial blood vessels market was valued at USD 2.19 billion in 2023, growing at a CAGR of 5.02% during the forecast period from 2024 to 2030 to reach USD 3.07 billion by 2030.
The demand for artificial blood vessels is primarily being boosted by the increasing patient population suffering from various heart conditions benefits of artificial blood vessels for vascular obstruction, and continuous innovation in product development among others, thereby contributing to the overall growth of the Artificial Blood Vessels market during the forecast period from 2024-2030.
Some of the key market players operating in the artificial blood vessels market include LeMaitre Vascular Inc., Terumo Medical Corporation, W. L. Gore and Associates, B. Braun SE, Roumai Med, Jiangsu Bioda Life Science Co. Ltd., Artivion, Inc., Getinge, Vygon, and others.
North America is expected to dominate the overall artificial blood vessels market during the forecast period from 2024-2030. Owing to factors such as the rise in the number of people with cardiovascular diseases, the surge in the number of awareness programs and initiatives for heart health, high disposable income, sophisticated healthcare infrastructure, and high awareness among others, North American artificial blood vessels market is expected to growth in coming years.